Cell-Membrane Nanoparticles With SpyTag Anchoring for Targeted Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for anchoring soluble protein ligands onto cell membranes are challenging due to issues like misfolding, low expression levels, high costs, and time-consuming processes, limiting the scalability and versatility of cellular nanoparticles for biomedical applications.

Innovation Solution

A modular functionalized nanoparticle system using genetically engineered cell membranes expressing anchor proteins like SpyCatcher, which form irreversible covalent bonds with tag-modified ligands, enabling rapid and efficient attachment of a wide range of functional substances without extensive post-processing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional methods are used to anchor soluble protein ligands onto cell membranes, then the ligands can be attached to the nanoparticle surface, but the process suffers from misfolding, low expression levels, high costs, and time-consuming procedures

Engineering Contradiction:
Improveproduction speedVSAvoidligand functionality
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The system divides the anchoring process into two independent segments: (1) the cell membrane is engineered to express a surface-bound membrane anchor protein (SpyCatcher), and (2) the soluble ligand is modified with a tag sequence (SpyTag) that conjugates with the anchor. This segmentation allows each component to be optimized independently, eliminating misfolding issues that occur when attempting to directly fuse ligands to the membrane.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The cell membrane is pre-engineered to express the SpyCatcher anchor protein before nanoparticle formation. This preliminary action ensures that the anchor is already in place and properly folded on the membrane surface, ready to rapidly capture the SpyTag-modified ligands during or after nanoparticle assembly, thereby eliminating time-consuming post-processing steps.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If extensive post-processing is performed to ensure proper ligand anchoring, then ligand functionality is improved, but the process becomes more time-consuming and less scalable

Engineering Contradiction:
Improveligand functionalityVSAvoidprocessing time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The SpyCatcher-SpyTag system enables self-service anchoring where the ligand automatically binds to the membrane anchor through irreversible covalent bond formation. This self-assembling process occurs spontaneously without requiring external enzymes, harsh chemicals, or extensive post-processing, thereby eliminating time loss while ensuring proper ligand functionality.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The system changes the binding parameter from reversible/weak interactions to irreversible covalent bonds through the SpyCatcher-SpyTag chemistry. This parameter change ensures that once the ligand binds to the membrane anchor, it remains stably attached without requiring additional processing steps to maintain functionality, thus reducing processing time while ensuring reliability.

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If a fixed nanoparticle design is used, then manufacturing is simpler, but the system lacks versatility to target different cell types

Engineering Contradiction:
Improvecell targeting capabilityVSAvoidnanoparticle structure
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The nanoparticle system achieves universality through the SpyCatcher anchor, which can bind to any SpyTag-modified ligand. This means a single nanoparticle platform with SpyCatcher-expressing membranes can be used to target multiple different cell types by simply changing the ligand (e.g., anti-EGFR for epithelial cells, anti-HER2 for breast cancer cells, anti-GP100 for melanoma cells), without requiring different nanoparticle structures.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The SpyCatcher-SpyTag pair acts as a universal intermediary that mediates between the nanoparticle platform and various target ligands. The SpyCatcher on the membrane serves as a universal docking site that can accommodate any SpyTagged molecule, thereby enabling one nanoparticle design to achieve multiple targeting functions through ligand exchange rather than structural modification.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Stability of the object's composition

If complex anchoring procedures are used to ensure stable ligand attachment, then attachment stability is improved, but the process becomes more costly and less scalable

Engineering Contradiction:
Improveligand-membrane bond stabilityVSAvoidmanufacturing scalability
Core Design Contradiction:
Stability of the object's compositionVSEase of manufacture

Solution Approach 1:

The system replaces complex mechanical/chemical anchoring procedures with a biochemical self-assembly mechanism. The SpyCatcher-SpyTag interaction occurs through spontaneous covalent bond formation driven by molecular recognition, eliminating the need for complex instrumentation, multiple processing steps, or expensive reagents, thereby achieving stable attachment that is both easy to manufacture and scalable.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Facilitates rapid production of scalable, versatile, and cost-effective cellular nanoparticles capable of targeted delivery and interaction with various cell types, enhancing applications in biomedical fields such as cancer treatment.

Implementation Method 1

which forms irreversible covalent bonds with tag-modified ligands

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Implementation Method 2

a tag molecule having a specific binding affinity to the anchor compound and bound to the anchor compound

Methodology Applied
Scientific EffectSpecific binding affinity: Adsorption

Data Source

PatentUS20260069711A1Systems, devices and methods for modular functionalized cellular nanostructures for targeted payload delivery
Publication Date: 2026.03.12 RGT UNIV OF CALIFORNIA
  • US20260069711A1 patent drawing
  • US20260069711A1 patent drawing
  • US20260069711A1 patent drawing

AI summary

Disclosed are devices, systems, and methods of manufacture and use of modular functionalized cellular nanoparticles that can bind a wide range of ligands, payloads, and functional substances onto a nanoparticle surface. In various embodiments, a cell membrane coating on the nanoparticle is engineered to express a membrane anchor that can readily form a covalent bond with any functional moiety modified with an appropriate peptide tag sequence.